What are the impacts of the Health Ministry's decision to bar export of unapproved drug combination

- **Protection of Public Health**: The decision to bar the export of unapproved drug combinations by the Health Ministry will help in safeguarding public health by ensuring that only safe and effective medications are being exported. - **Regulatory Compliance**: This move will encourage pharmaceutical companies to comply with regulatory standards and get proper approval for their drug combinations before exporting them, ultimately improving the overall quality and safety of medications. - **Prevention of Unintended Consequences**: Exporting unapproved drug combinations can lead to negative consequences such as drug resistance, adverse effects, and treatment failures. This decision helps in minimizing these risks and promoting responsible drug manufacturing practices. - **Enhanced Accountability**: Pharmaceutical companies will be held accountable for the products they export, which can help in maintaining transparency and accountability in the healthcare industry.